NCT06924008 Developing an Intervention Facilitating the Use of Eye Contact in Adults With Autism
| NCT ID | NCT06924008 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UMC Utrecht |
| Condition | Autism Spectrum Disorder (ASD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 18 participants |
| Start Date | 2025-07-07 |
| Primary Completion | 2026-07-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 18 participants in total. It began in 2025-07-07 with a primary completion date of 2026-07-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to develop a methodological intervention for adults with autism that will help them reduce problems arising from eye contact.
Eligibility Criteria
Inclusion criteria for adults with autism * Adults classified with autism, determined according to an internationally recognized classification system. * Outpatient treatment within a specialized autism center in the Netherlands. * Able to understand the topics to be discussed. * Motivation to participate in research. Exclusion criteria for adults with autism * No good command of the Dutch language. * Use of alcohol and/or recreational drugs during the study. * Mentally too unstable to participate in the study. * Familiarity with treatment in the VGZ. Inclusion criteria for those involved * Adults without DSM classification. * Living in the Netherlands. * Able to understand the topics to be discussed. * Motivation to participate in research. Exclusion criteria for those involved * No good command of the Dutch language. * Use of alcohol and/or recreational drugs during the study. Inclusion criteria for healthcare providers * Practicing psychiatrist, clinical psychologist or nurse specialist at an autism expertise center in the Netherlands. * Living in the Netherlands. * Motivation to participate in research. Exclusion criteria for healthcare providers \- No good command of the Dutch language.
Contact & Investigator
Nynke Boonstra, Professor
STUDY CHAIR
UMC Utrecht
Frequently Asked Questions
Who can join the NCT06924008 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Autism Spectrum Disorder (ASD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06924008 currently recruiting?
Yes, NCT06924008 is actively recruiting participants. Contact the research team at j.c.boer-30@umcutrecht.nl for enrollment information.
Where is the NCT06924008 trial being conducted?
This trial is being conducted at Deventer, Netherlands.
Who is sponsoring the NCT06924008 clinical trial?
NCT06924008 is sponsored by UMC Utrecht. The principal investigator is Nynke Boonstra, Professor at UMC Utrecht. The trial plans to enroll 18 participants.